• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Herbalife Ltd. (Amendment)

    2/13/24 5:06:16 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care
    Get the next $HLF alert in real time by email
    SC 13G/A 1 tv01107-herbalifeltd.htm SCHEDULE 13G/A herbalifeltd

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G

    Under the Securities Exchange Act of 1934
    (Amendment No.: 9)*

    Name of issuer:  Herbalife Ltd

    Title of Class of Securities:  Common Stock

    CUSIP Number:  G4412G101

    Date of Event Which Requires Filing of this Statement: December 29, 2023

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☒ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    (Continued on the following page(s))

     

     

    13G

    CUSIP No.:  G4412G101

    1.  NAME OF REPORTING PERSON
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

    The Vanguard Group - 23-1945930

    2.  CHECK THE APPROPRIATE [LINE] IF A MEMBER OF A GROUP

    A. 

    B.  X

    3.  SEC USE ONLY

    4.  CITIZENSHIP OF PLACE OF ORGANIZATION

    Pennsylvania

    (For questions 5-8, report the number of shares beneficially owned by each reporting person with:)

    5.  SOLE VOTING POWER

    0

    6.  SHARED VOTING POWER

    151,533

    7.  SOLE DISPOSITIVE POWER

    10,009,470

    8.  SHARED DISPOSITIVE POWER

    251,609

    9.  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    10,261,079

    10.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    N/A

    11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

    10.35%

    12.  TYPE OF REPORTING PERSON

    IA

     

     

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G
    Under the Securities Act of 1934

    Item 1(a) - Name of Issuer:

    Herbalife Ltd

    Item 1(b) - Address of Issuer's Principal Executive Offices:

    800 West Olympic Boulevard, Suite 406
    Los Angeles, CA 90015

    Item 2(a) - Name of Person Filing:

    The Vanguard Group - 23-1945930

    Item 2(b) – Address of Principal Business Office or, if none, residence:

    100 Vanguard Blvd.
    Malvern, PA 19355

    Item 2(c) – Citizenship:

    Pennsylvania

    Item 2(d) - Title of Class of Securities:

    Common Stock

    Item 2(e) - CUSIP Number

    G4412G101

    Item 3 - Type of Filing:

    This statement is being filed pursuant to Rule 13d-1.  An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).

    Item 4 - Ownership:

      (a) Amount Beneficially Owned:

      (b) Percent of Class:

     

     

    (c)  Number of shares as to which such person has:

    (i)  sole power to vote or direct to vote:  

    (ii)  shared power to vote or direct to vote:  

    (iii)  sole power to dispose of or to direct the disposition of:  

    (iv)  shared power to dispose or to direct the disposition of:  

    Comments:

    The responses to questions 5 through 9 and 11 on the cover page(s) are incorporated by reference into this Item 4.  

    Item 5 - Ownership of Five Percent or Less of a Class:

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ☐

    Item 6 - Ownership of More Than Five Percent on Behalf of Another Person:

    The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.

    No one other person's interest in the securities reported herein is more than 5%.

    Item 7 - Identification and Classification of the Subsidiary Which Acquired The Security Being Reported on by the Parent Holding Company:

    Not applicable

    Item 8 - Identification and Classification of Members of Group:

    Not applicable

    Item 9 - Notice of Dissolution of Group:

    Not applicable

    Item 10 - Certification:

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.

    Signature

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date:  February 13, 2024

    By /s/ Ashley Grim
    Name: Ashley Grim
    Title:  Head of Global Fund Administration

    Get the next $HLF alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $HLF

    DatePrice TargetRatingAnalyst
    3/21/2025$7.50 → $14.00Neutral → Buy
    DA Davidson
    8/1/2024$16.00 → $17.00Buy
    B. Riley Securities
    9/14/2023$13.50Neutral
    DA Davidson
    6/7/2023$13.00Neutral
    Mizuho
    2/3/2023$14.00Underperform
    BofA Securities
    7/12/2022$26.00Hold → Buy
    Jefferies
    5/17/2022Buy → Hold
    Argus
    5/4/2022$60.00 → $26.00Buy → Hold
    Jefferies
    More analyst ratings

    $HLF
    SEC Filings

    See more
    • Herbalife Ltd. filed SEC Form 8-K: Other Events

      8-K - HERBALIFE LTD. (0001180262) (Filer)

      6/16/25 4:01:24 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife Ltd. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - HERBALIFE LTD. (0001180262) (Filer)

      4/30/25 4:40:01 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • SEC Form 10-Q filed by Herbalife Ltd.

      10-Q - HERBALIFE LTD. (0001180262) (Filer)

      4/30/25 4:16:43 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care

    $HLF
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Herbalife Launches MultiBurn™: A Science-Backed Weight Loss Supplement Supporting Metabolic Health

      New daily supplement features clinically studied botanicals to support weight loss, healthy fat reduction and energy expenditure* Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced the launch of MultiBurn™ — a next-generation multi-action dietary supplement designed with clinically studied botanical extracts to support key areas of metabolic health*. Formulated by Herbalife's global team of scientists and nutrition experts, MultiBurn™ is gluten-free, suitable for vegans and made without synthetic colors or dyes, reflecting the company's commitment to clean-label, user-friendly wellness solutions. This press release features multimedi

      7/7/25 8:19:00 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife to Announce Second Quarter 2025 Results on August 6

      Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, will release its second quarter 2025 financial results after the close of trading on the NYSE on Wednesday, August 6, 2025. On the same day, at 5:30 p.m. ET (2:30 p.m. PT), Herbalife's senior management team will host an audio webcast and conference call to discuss its recent financial results. The audio webcast will be available at the following link: https://edge.media-server.com/mmc/p/2syhpnp7 Participants joining via the conference call may obtain the dial-in information and personal PIN to access the call by registering at the following link: https://register-conf.media-server.com/register/BI5

      7/1/25 7:05:00 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife Named in U.S. News & World Report's 2025-2026 Best Companies to Work For List

      Recognized for Workplace Excellence, Employee Experience and Career Growth Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, has been named one of U.S. News & World Report's 2025-2026 Best Companies to Work For. Recognized globally for its authoritative rankings and trusted consumer guidance, U.S. News & World Report helps individuals make informed decisions across careers, education, and more. This distinction reflects Herbalife's ongoing commitment to building a purpose-driven community, people-first culture focused on employee wellbeing and growth. This press release features multimedia. View the full release here: https://www.businesswire.com/n

      6/26/25 7:02:00 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care

    $HLF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Mendoza Juan Miguel bought $23,572 worth of shares (3,143 units at $7.50), increasing direct ownership by 2% to 170,000 units (SEC Form 4)

      4 - HERBALIFE LTD. (0001180262) (Issuer)

      6/9/25 6:00:12 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Director Mendoza Juan Miguel bought $33,750 worth of shares (5,000 units at $6.75), increasing direct ownership by 3% to 166,857 units (SEC Form 4)

      4 - HERBALIFE LTD. (0001180262) (Issuer)

      5/23/25 4:01:25 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Director Mendoza Juan Miguel bought $33,650 worth of shares (5,000 units at $6.73) and was granted 21,857 shares, increasing direct ownership by 20% to 161,857 units (SEC Form 4)

      4 - HERBALIFE LTD. (0001180262) (Issuer)

      5/6/25 8:19:33 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care

    $HLF
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Herbalife Nutrition upgraded by DA Davidson with a new price target

      DA Davidson upgraded Herbalife Nutrition from Neutral to Buy and set a new price target of $14.00 from $7.50 previously

      3/21/25 8:38:07 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • B. Riley Securities reiterated coverage on Herbalife Nutrition with a new price target

      B. Riley Securities reiterated coverage of Herbalife Nutrition with a rating of Buy and set a new price target of $17.00 from $16.00 previously

      8/1/24 8:12:23 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • DA Davidson initiated coverage on Herbalife Nutrition with a new price target

      DA Davidson initiated coverage of Herbalife Nutrition with a rating of Neutral and set a new price target of $13.50

      9/14/23 7:19:53 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care

    $HLF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Mendoza Juan Miguel bought $23,572 worth of shares (3,143 units at $7.50), increasing direct ownership by 2% to 170,000 units (SEC Form 4)

      4 - HERBALIFE LTD. (0001180262) (Issuer)

      6/9/25 6:00:12 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Director Mendoza Juan Miguel bought $33,750 worth of shares (5,000 units at $6.75), increasing direct ownership by 3% to 166,857 units (SEC Form 4)

      4 - HERBALIFE LTD. (0001180262) (Issuer)

      5/23/25 4:01:25 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • New insider Levy Robert claimed ownership of 449,358 shares (SEC Form 3)

      3 - HERBALIFE LTD. (0001180262) (Issuer)

      5/12/25 7:39:33 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care

    $HLF
    Leadership Updates

    Live Leadership Updates

    See more
    • Herbalife Welcomes Lynda Cloud to its Board of Directors

      Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced the election of Lynda Cloud to its Board of Directors, effective April 23, 2025. This appointment reflects Herbalife's continued commitment to innovation, digital transformation, and personalized wellness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250425107883/en/Herbalife Welcomes Lynda Cloud to the Board of Directors Lynda Cloud's decades of leadership across education, technology, and health sectors make her uniquely equipped to support Herbalife's next chapter. Her deep expertise in digital learning, consumer experie

      4/25/25 5:12:00 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife Appoints Stephan Gratziani as Chief Executive Officer

      Current CEO Michael Johnson Transitions to Executive Chairman Herbalife Ltd. (NYSE:HLF) today announced its Board of Directors has appointed President, Stephan Gratziani as Chief Executive Officer (CEO) effective May 1, 2025. Michael Johnson, current CEO and Chairman of the Board, will transition to Executive Chairman. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250219653469/en/Herbalife appoints Stephan Gratziani as Chief Executive Officer (Photo: Business Wire) As a former Herbalife independent distributor, Mr. Gratziani built and grew his international business into one of the top global distributorships. For 32 years, he

      2/19/25 4:05:00 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife Expands Board of Directors with Appointment of Perkins Miller

      Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today welcomed experienced e-commerce and media technology executive Perkins Miller to its board of directors. Miller's appointment as an independent director is effective June 26, 2024. "Perkins brings valuable, proven expertise in leading large-scale e-commerce, technology and sports enterprises, which will be a great asset to our Board as the Company continues to grow and transform," said Michael Johnson, Chairman and CEO of Herbalife. Miller is the CEO of Fandom, the world's largest fan platform where fans immerse themselves in imagined worlds across entertainment and gaming, where he has trans

      6/26/24 7:05:00 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care

    $HLF
    Financials

    Live finance-specific insights

    See more
    • Herbalife to Announce Second Quarter 2025 Results on August 6

      Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, will release its second quarter 2025 financial results after the close of trading on the NYSE on Wednesday, August 6, 2025. On the same day, at 5:30 p.m. ET (2:30 p.m. PT), Herbalife's senior management team will host an audio webcast and conference call to discuss its recent financial results. The audio webcast will be available at the following link: https://edge.media-server.com/mmc/p/2syhpnp7 Participants joining via the conference call may obtain the dial-in information and personal PIN to access the call by registering at the following link: https://register-conf.media-server.com/register/BI5

      7/1/25 7:05:00 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife Reports Q1 Net Sales at Midpoint of Guidance Range, Net Sales Growth Excluding FX Headwinds1; Q1 Adjusted EBITDA2 Exceeds Guidance; Updates Full-Year Guidance

      Herbalife Ltd. (NYSE:HLF) today reported financial results for the first quarter ended March 31, 2025: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250430667438/en/ "Our first quarter results were strong, and we raised our full-year 2025 Adjusted EBITDA2 expectations. Our recent acquisitions strengthen our position and support our commitment to transformative growth," Stephan Gratziani, President and incoming CEO (effective May 1 '25). Highlights First Quarter 2025 Net sales of $1.2 billion at midpoint of guidance range Down 3.4% vs. Q1 ‘24 Includes 480 basis points of FX headwinds Up 1.4% year-over-year on constant cu

      4/30/25 4:10:00 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife to Announce First Quarter 2025 Results on April 30

      Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, will release its first quarter 2025 financial results after the close of trading on the NYSE on Wednesday, April 30, 2025. On the same day, at 5:30 p.m. ET (2:30 p.m. PT), Herbalife's senior management team will host an audio webcast and conference call to discuss its recent financial results. The audio webcast will be available at the following link: https://edge.media-server.com/mmc/p/bd8j8th6 Participants joining via the conference call may obtain the dial-in information and personal PIN to access the call by registering at the following link: https://register-conf.media-server.com/register/BI1210

      4/1/25 7:05:00 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care

    $HLF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Herbalife Ltd.

      SC 13G/A - HERBALIFE LTD. (0001180262) (Subject)

      11/14/24 4:11:11 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • SEC Form SC 13G filed by Herbalife Ltd.

      SC 13G - HERBALIFE LTD. (0001180262) (Subject)

      11/13/24 4:01:31 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Herbalife Ltd.

      SC 13G/A - HERBALIFE LTD. (0001180262) (Subject)

      11/13/24 12:49:27 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care